11/12
07:23 am
zbio
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Low
Report
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
11/12
07:10 am
zbio
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Low
Report
Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/12
07:05 am
zbio
Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
Low
Report
Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
11/7
07:05 am
zbio
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
Low
Report
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
10/22
06:28 pm
zbio
Zenas Bio: Recent IPO With Late-Stage Candidate [Seeking Alpha]
Medium
Report
Zenas Bio: Recent IPO With Late-Stage Candidate [Seeking Alpha]
9/19
04:15 pm
zbio
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
Medium
Report
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
9/12
10:47 pm
zbio
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering [Financial Post (Toronto, Ontario, Canada)]
9/12
10:37 pm
zbio
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
Low
Report
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering